The efficacy of lidocaine for postoperative catheter-related bladder discomfort

The efficacy of lidocaine for postoperative catheter-related bladder discomfort in male patients undergoing transurethral resection of bladder tumor

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0003030

Enrollment

132

Registered

2018-07-26

Start date

2018-09-03

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Before induction of anesthesia, patients in experimental group will be given an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous infusion of 2 mg/kg/h. The lidocaine

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Patients undergoing transurethral resection of bladder tumor under general anesthesia 2) Patients = 20 years of age, Patients < 80 years of age 3) American Society of Anesthesiologists (ASA) physical status: 1-2 4) Patients who voluntarily agreed to participate in this clinical study

Exclusion criteria

Exclusion criteria: 1) Significant arrhythmia (sinus bradycardia, heart block, atrial fibrillation) 2) Heart failure (ejection fraction = 40%) 3) Coronary artery disease 4) Liver cirrhosis 5) Chronic kidney disease 6) Allergy to local anesthetics

Design outcomes

Primary

Measure	Time frame
The difference in the severity of CRBD between group L and group C	—

Secondary

Measure	Time frame
The nature of CRBD (Distress in the supra-pubic area, burning sensation, and urge to urinate);Intensity of postoperative pain (Numeric rating scale);Postoperative analgesic consumption;Postoperative complications and side effects of lidocaine;The difference in the severity of CRBD between group L and group C;Patient satisfaction	—

Countries

Korea, Republic of

Contacts

Public ContactDoo-Hwan Kim

Asan Medical Center

knaaddict@gmail.com+82-2-3010-1417

Outcome results